Burst ketamine to reverse opioid tolerance in cancer pain [3]

Journal of Pain and Symptom Management

Volumn 25, Issue 4, 2003, Pages 302-305

  Mercadante, Sebastiano ^a   Villari, Patrizia ^a   Ferrera, Patrizia ^a  

^a LA MADDALENA CANCER CENTER   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

KETAMINE; METHADONE; MORPHINE; OPIATE; PAMIDRONIC ACID;

AGED; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER PAIN; CANCER RADIOTHERAPY; CASE REPORT; CLINICAL FEATURE; COGNITIVE DEFECT; DOSE RESPONSE; DRUG INFUSION; DRUG TOLERANCE; FEMALE; HUMAN; LETTER; METHADONE TREATMENT; SPINAL CORD METASTASIS;

AGED; ANALGESICS, OPIOID; DRUG TOLERANCE; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; HUMANS; KETAMINE; NEOPLASMS; PAIN;

EID: 0037385039     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0885-3924(03)00047-2     Document Type: Letter

References (17)

1. Expert Working Group of the European Association for Palliative Care Morphine in cancer pain. modes of administration BMJ. 312:1996;823-826.
2. Portenoy R.K., Foley K.M., Inturrisi C.E. The nature of opioid responsiveness and its implications for neuropathic pain. new hypothesies derived from studies of opioid infusions Pain. 43:1990;273-286.
3. Mercadante S. Predictive factors and opioid responsiveness in cancer pain. Eur J Cancer. 34:1998;627-631.
4. Bruera E., MacMillan D., Hanson J., MacDonald R.N. The Edmonton staging system for cancer pain. preliminary report Pain. 37:1989;203-210.
5. Mercadante S. Ketamine in cancer pain. An update. Palliat Med. 10:1996;225-230.
6. Crain S.M., Shen K.F. Antagonists of excitatory opioid receptor functions enhance morphine's analgesic potency and attenuate opioid tolerance/dependence liability. Pain. 84:2000;121-131.
7. Bell R.F. Low-dose subcutaneous ketamine infusion and morphine tolerance. Pain. 83:1999;101-103.
8. Jackson K., Ashby M., Martin P.et al. Burst ketamine for refractory cancer pain. an open-label audit of 39 patients J Pain Symptom Manage. 22:2001;834-842.
9. Mayer D.J., Mao J., Price D.D. The development of morphine tolerance and dependence is associated with translocation of protein kinase C. Pain. 61:1995;365-374.
10. Wu J., Fang L., Lin Q., Willis W.D. Nitric oxide synthase in spinal cord central sensitization following intradermal injection of capsaicin. Pain. 94:2001;47-58.
11. Mao J., Price D., Mayer D.J. Experimental mononeuropathy reduces the antinociceptive effects of morphine. implications for common intracellular mechanisms involved in morphine tolerance and neuropathic pain Pain. 61:1995;353-364.
12. Mao J.R., Price D.D., Mayer D.J. Mechanisms of hyperalgesia and morphine tolerance. a current view of their possible interactions Pain. 62:1995;259-274.
13. Coderre T.J., Katz J., Vaccarino A.L., Melzack R. Contribution of central neuroplasticity to pathological pain. review of clinical and experimental evidence Pain. 52:1993;259-285.
14. Andersen O., Felsby S., Nicolaisen L.et al. The effect of ketamine on stimulation of primary and secondary hyperalgesic areas induced by capsaicin - a double-blind, placebo-controlled, human experimental study. Pain. 66:1996;51-62.
15. Persson J., Axelsson G., Hallin R., Gustafsson L. Beneficial effects of ketamine in a chronic pain state with allodynia, possibly due to central sensitization. Pain. 60:1995;217-222.
16. Mercadante S, Portenoy RK. Opioid poorly responsive cancer pain. Part 2. Basic mechanisms that could shift dose-response for analgesia. J Pain Symptom Manage 2001;21:255-264.
17. Mao J. Translational pain research. bridging the gap between basic and clinical research Pain. 97:2002;183-187.